LH parallel decline
Among these medications are Ozempic, Wegovy, and Rybelsusall GLP-1 agonists manufactured by Novo Nordisk
Sources History of glucagon-like peptide-1 receptor agonists (ScienceDirect) Mechanisms of GLP-1 Receptor Agonist Induced Weight Loss (The American Journal of Medicine) Real-world weight loss with semaglutide 2.4 mg or tirzepatide, approval dates (Advances in Therapy, Springer) FDA Approves New Medication for Chronic Weight Management, Zepbound (U.S
Ibuprofen (200400 mg every 68 hours with food, maximum 1.2 g daily for over-the-counter use) may be used if paracetamol proves insufficient, provided you have no contraindications such as kidney disease, cardiovascular conditions, gastric ulcer history, or pregnancy (especially after 20 weeks)
With regards to the oral disposition index, the high GLP-1 group demonstrated significant increment following 12 weeks of treatment with linagliptin [LS-mean change 1.17 (95% CI 0.43, 1.91)]
This is the same mechanism targeted by topical brightening agents, delivered systemically instead, and the effect is best understood as a gradual, cumulative brightening support across a series rather than an overnight change